Indalo Therapeutics

4320 Forest Park Avenue
Suite 304
St. Louis
United States

Tel: 314-932-4032 X317

NextGen Class of 2018
Show jobs for this employer

About Indalo Therapeutics

Indalo Therapeutics is a preclinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating fibrotic diseases. Founded on groundbreaking scientific discoveries and leveraging cutting-edge insight into the molecular drivers of aberrant scarring, Indalo is harnessing the collective experience of a seasoned team of pharmaceutical scientists and executives to tackle some of the most urgent unmet medical needs in the fibrosis space.


October 2016


Founder and CMO: Williamson Z. Bradford, M.D., Ph.D.

Founder and CSO: Scott D. Seiwert, Ph.D.

Sr. VP of Pharmaceutical Development: Ramachandran Radhakrishnan, Ph.D.

Sr. VP of Translational Science: Karl Kossen, Ph.D.

VP and Head of Business Operations: George H. Capps, M.S., M.B.A.

12 articles about Indalo Therapeutics